I can't stand football https://drugmart.lk/missouri-baptist-pharmacy-residency-alp5 baptist pharmacy columbus ms Anuoluwapo Osinusi, M.D., M.P.H., from the National Institutes of Health in Bethesda, Md., and colleagues studied a total of 60 treatment-naive patients infected with HCV with liver fibrosis. Of these, 10 with early to moderate fibrosis were treated with sofosbuvir (400 mg/day) and ribavirin (weight-based) for 24 weeks. The remaining 50 (with all stages of liver fibrosis) were randomly assigned to sofosbuvir (400 mg/day) and either weight-based or low-dose (600 mg/day) ribavirin for 24 weeks.
(携帯) |